New Delhi [India], October 9 (ANI): US-based pharmaceutical company Eli Lilly and Company has announced plans to invest more than USD one billion in India over the next several years, marking one of the largest foreign investments in the country's healthcare manufacturing sector in recent years. Union Minister of Commerce and Industry, Piyush Goyal, welcomed the investment and highlighted the growing presence of India in the global ecosystem.

On Wednesday, in a post on X, Goyal said, "We welcome @EliLillyandCo's $1bn investment in India! This reaffirms our nation's position as a global hub for innovation, R&D, manufacturing, and healthcare solutions. Under PM @NarendraModi ji's leadership, India has made remarkable progress in enhancing Ease of Doing Business and building global trust in its quality ecosystem that has made it one of the most preferred investment destinations."

Also Read | Gaza Peace Plan: In Historic Breakthrough, Israel and Hamas Agree on First Phase Peace Deal Proposed by US President Donald Trump; Hostages to Be Released.

Eli Lilly and Company (India) has announced plans to invest in new contract manufacturing in India, thereby expanding patients' access to innovative medicines worldwide.

This strategic investment will further strengthen manufacturing and supply capabilities to support Lilly's evolving portfolio. In addition, the company will establish a new Manufacturing and Quality presence in Hyderabad.

Also Read | Shoe Attack on CJI BR Gavai: Karnataka Police File FIR Against Accused Lawyer Rakesh Kishore for His Act of Trying to Throw Shoe at the Chief Justice of India.

The move is expected to create thousands of job opportunities for the state's youth and further strengthen Hyderabad's position as a global life sciences and pharmaceutical hub.

The announcement came after a delegation from Eli Lilly met Chief Minister A Revanth Reddy and Industries Minister D. Sridhar Babu at the Integrated Command Control Centre on Monday.

This latest investment, one of the largest in recent years, comes just months after the inauguration of Eli Lilly's Global Capability Centre (GCC) in Hyderabad on August 4. The new facilities will expand the company's manufacturing capacity and global supply operations, focusing on medicines to treat diabetes, obesity, cancer, Alzheimer's disease, and autoimmune conditions.

"Telangana means business. Hyderabad is a global city. Our government will support and welcome all industries looking to invest here," said Chief Minister Revanth Reddy, reaffirming the state's commitment to fostering a conducive environment for global investors.

The Chief Minister thanked the Eli Lilly leadership for choosing Telangana and assured full government support for future expansions. (ANI)

(The above story is verified and authored by ANI staff, ANI is South Asia's leading multimedia news agency with over 100 bureaus in India, South Asia and across the globe. ANI brings the latest news on Politics and Current Affairs in India & around the World, Sports, Health, Fitness, Entertainment, & News. The views appearing in the above post do not reflect the opinions of LatestLY)